Want to know how the White House is awarding Covid-19 vaccine contracts? Too bad
Regulations prohibit federal agencies from providing information both on the evaluation process and on the negotiations to reach an award amount.
Out of all the actions the US government has—and has not—taken against the Covid-19 pandemic, only one has seen consistent effort: Investing in medical countermeasures.The US has so far spent over $9 billion, mostly by awarding research and development contracts for testing, treatment, and vaccine. The latest such award, and largest yet, was $2.04 billion given to French pharmaceutical company Sanofi, together with GlaxoSmithKline, on July 30, to support clinical trials and manufacturing demonstrations. The US also reserved the right to acquire 500 million doses of the vaccine under development should it prove effective. The same project received about